Introduction
The mucins synthesized and secreted by the mucosal cells lining the gastrointestinal tract form a vital part of the total mucosal secretion giving rise to the extracellular barrier. The supramucosal barrier forms the primary line of defence for the mucosa against attack from the external environment, including all manner of micro-organisms, biochemical agents and mechanical stresses. Mucins from each section of the gastrointestinal tract have a typical carbohydrate and mucin gene product composition reflecting their function at each location [ 1, 2] . Both the secreted mucins, forming the extracellular gels [3] , and cell membrane-associated (glycocalyx) mucins, typically MUC1 type and involved in cell-surface interactions [4] , are implicated in the cell-surface and supramucosal layer changes occurring during gastrointestinal cancer and inflammatory bowel diseases such as ulcerative colitis (UC) [2, 5] . In addition, enzymes secreted by the normal enteric bacterial flora continually degrade mucins in the mucosal barrier in a controlled manner, allowing an equilibrium to be maintained between synthesis, secretion, degradation and an efficient protective function. Modifications in the structure of the mucosal barrier mucins influence the rate of degradation and therefore the viability of the defensive barrier.
Mucin sialylation and 0-acetylation
The range of sialylated structures present in colonic mucins has provided a valuable aid in the detection and staging of normal and disease processes. The mucins in the human colon are rich in sialic acids. At least 30% are substituted by dior tri-0-acetyl esters and 15% occur as mono-0-acetyl esters, so that in total almost 50% of all sialic acids in normal colonic mucins are 0-acetylated in European populations [6-81. The presence of 0-acetylated sialic acids has been determined by histochemical methods, most effectively using the mild periodic acid-Schiff (mPAS) technique, and also with several antibodies that also show cross-reactivity with 0-acetylated sialic acids. 0-Acetylated sialic acids have also been identified after metabolic labelling with D-glucosamine [O, lo] , and reduction in sialic acid 0-acetylation occurs in human colorectal cancer [9, 10] and at very early stages of malignant transformation in cultured human colorectal adenoma cells (Figure 1 ) derived from a premalignant polyposis coli cell line developing into adenocarcinoma or mucinous carcinoma [9] and other malignant colon cell lines [ 111.
The detection of normal levels of mono-0-acetyl sialic acids in individual colorectal cancer mucins and in cultured cell line mucins [9] has been supported by immunohistological staining using influenza C virus, which specifically detects the 9(7)-mono-O-acetylsialic acids [ 12, 131 . This result has prompted us to propose that there are two independent types of sialic acid 0-acetylation, mono and poly. Mono-0-acetylation is widespread [ 141, while poly-0-acetylation appears to be colon specific in man.
A natural genetic variation of colonic mucin poly-0-acetylated sialic acid has been established using histochemical analysis with the mPAS reaction. This is approx. 7% of normal Europeans but >40% of Hong Kong and Japanese populations [7] . T h e mPAS staining patterns are consistent with the loss of a single polymorphic gene, responsible for sialic acid 0-acetylation [7] . In cultured colorectal cancer cells and in individual cancer patients a loss of sialic acid 0-acetylation has been found. In the cultured cell lines this loss was present in the earliest premalignant cell lines tested and suggests that this is a very early response to transformation in the adenoma-carcinoma sequence [9] . The location of the 0-acetylated sialic acids in colonic mucin oligosaccharides has not been determined. The majority of oligosaccharides in normal colonic mucins contain 4-12 monosaccharides, and are both sialylated and sulphated. Detailed structural analysis is still outstanding. However, shorter oligosaccharide structures have also been identified and linked with the appearance of malignancy and metastasis [15] . Of particular note here is the sialyl-Tn epitope, which has been described as a general cancer marker [ 161. However, recent evidence has indicated that the antigenic nature of these structures and their detection may be influenced by 0-acetylation [ 171. In addition, mucin-linked sialyl-Lewis" has been associated with malignancy and metastasis [ 18,191 although the relationship to 0-acetylation has not been assessed. In cultured human colorectal cells the presence of sialyl-Lewis" occurs in early premalignant adenoma arid mucinous carcinoma cell line mucins, while sialyl-Tn appears only in mucinous carcinoma mucins [20] . In these cell lines no sialic acid O-acetylation was present. Examination of sialyltransferase activity in these cell lines has shown the loss of an a2-6 activity with a GalNAc-0-Thr substrate, which may account for the loss of the sialyl-Tn epitope [21] . Further examination of the sialyltransferases responsible for the biosynthesis of these structures is required. In ulcerative colitis, less information is available on sialylation. The patterns of 0-acetylation appear to be within the normal range except in advanced stages, when precancerous changes have been identified [S] .
Otherwise, the expected proportion of non-0-acetylators depending on genetic origin is observed [7, 8, 22] .
Mucin sulphation
T h e sulphation of mucin is a characteristic feature of the human colon, and contrasts with most other locations in the gastrointestinal tract [2, 8] . T h e biochemical analysis of colonic mucin sulphation has not been established chemically, although enzymic analyses suggest the presence of 3-0-sulphation of galactose [23] . Several studies have indicated that there is a loss of colonic mucin sulphation in ulcerative colitis [22, 24, 25] [29] . Further study has shown that the reduction in mucin sulphation is related to the severity of the disease and may have a genetic component. The typical loss of mucin sulphation was not found in a group of South Asian colitics at either the histochemical or biochemical level. A significantly reduced incidence of colitisrelated colorectal cancer occurs in these individuals compared with European patients with colitis, who generally have more severe disease, have a greater incidence of disease related colorectal cancer and show reduced mucin sulphation [22] . The loss of sulphotransferase activity associated with cultured colorectal cancer cells and colorectal cancer tissue suggests that this may be the primary defect. However, no data are yet available for sulphotransferase activity in ulcerative colitis or for an evaluation of any additional role played by the activation of sulphate to 3'-phosphoadenosyl 5'-phosphosulphate (PAPS) or its destruction in these disease situations. The metabolism of sulphate in gastrointestinal tissues remains poorly understood.
Sulphation of colorectal mucin is clearly a major feature that is susceptible to change in colonic disease. The effects of sulphate loss are likely to be reflected in the viscoelastic properties of the mucins synthesized in these diseases and may be part of the reason for the production of defective mucus seen in ulcerative colitis [30] . In addition, sulphation plays a regulatory role in the rate of mucin degradation by enteric bacterial enzymes and therefore contributes to the maintenance of the adherent mucosal defensive barrier.
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Mucin oligosaccharide glycosyltransferases
The pathways of mucin oligosaccharide formation are known. (Steps relevant to colorectal mucin synthesis are shown in Figure 2 .) These data have been gathered as a result of detailed oligosaccharide structural analysis and identification of individual enzyme steps and specificities [31] . The oligosaccharide structures described for normal human colonic mucins have characteristic properties [32, 33] , including 65-75% oligosaccharides with 4-12 sugars per chain, 30-40% neutral oligosaccharides, a predominance of core 3 (GlcNAcpl-3GalNAc-Ser/Thr)-based oligosaccharides, backbone structures based on Gal-GlcNAc repeats, branching at galactose residues, and the presence of sialic acids linked 012-6 to galactose and GalNAc. These observations have not yet been extended to cover the substitution of sulphate. However, the results do indicate the nature of the glycosyltransferases required for the biosynthesis of this complement of oligosaccharides [31] .
A detailed examination of the glycosyltransferase activities in colorectal mucosa and colorectal tumours [28, 34] and in a sequence of cultured human colonic cell 1i:ies representing stages of the adenoma-carcinoma sequence and culminating in a malignant adenocarcinoma line [35] has shown typical changes in the activity of a number of key glycosyltransferases [21] . These predict the structure of oligosaccharides formed in the cancer tissue or transformed cell lines. The known pathways and changes in enzyme expression are shown in Figure 2 . Although these changes are complex and arise from many different metabolic events, there are a number of principal glycosyltransferase changes in malignant transformation. These lead to a switch from core 3 (GlcNAcpl-3GalNAc-Ser/Thr) to core 1 (Galpl-3GalNAc-SerlThr) and core 2 (Galpl-3(GalNAcpl-6)GalNAc-Ser/Thr), a reduction in branching and a modification of sialylation [21, 28, 31] . There is thus a decrease in reactions competing with core 1 synthesis and extension, and synthesis of sialylated, fucosylated and extended, unbranched core 1 structures should be expected. A more detailed discussion of the nature and implications of these results has been presented [21, 28] .
Bacterial degradation of mucins
Mucin degradation in the normal gastrointestinal tract is a dynamic and regulated process serving to ensure that the supramucosal mucus layer is turned over in balance with its synthesis and secretion by the mucosal cells. The mucus layer loses its viscoelastic properties during this process owing to the breakdown of the adherent mucin gel under the influence of a range of degrading enzymes, including proteases, glycosidases and lipases [ 11. The rate of mucin degradation is directly linked to the defensive function of the adherent mucus gel. An imbalance between the rate of mucin synthesis and bacterial degradation will result in a defective barrier [3, 36] . The degradation of mucin oligosaccharides by enteric bacterial enzymes takes place by stepwise cleavage of monosaccharides from the non-reducing terminus of the chains. Regulation of the rate of degradation is therefore dependent on the efficient removal of these 'capping' structures. In colonic mucins these structures include sialic acids and their 0-acetyl esters, 0-sulphate esters and blood group A and B determinants, a-linked N-acetylgalactosamine and galactose.
Measurement of the glycosidase activities produced by the enteric bacterial population shows that those enzymes that remove chainterminating moieties may be rate limiting for overall mucin oligosaccharide degradation. The normal enteric bacterial flora include several mucin oligosaccharide-degrading strains, making up approx. 1% of the total population, which possess all of the enzymes necessary for the complete breakdown of mucin carbohydrate. These strains produce and secrete enzymes that benefit the entire bacterial flora [37] .
The regulation of oligosaccharide degradation in the colonic mucins constituting the defensive mucosal barrier is dependent on characteristic colon-specific structural features. Sialic acid di-and tri-0-acetylation has an inhibitory effect on human enteric bacterial sialidase activity [38] . Removal of the 0-acetyl esters abolishes this inhibition and allows the abundant sialidase activity secreted by the total flora effectVolume 23 ively to desialylate the oligosaccharide chains and allow further degradation by other glycosidases [38] . The removal of the sialic acid 0-acetyl esters is achieved by a sialic acid 0-acetyl esterase [38, 39] present at levels well below those of sialidase and in line with a regulatory role in overall oligosaccharide degradation [6] . Increases in the level of this esterase activity have been found in the total faecal extracts of ulcerative colitis patients and may therefore influence the rate of mucin breakdown in this disease [6] .
Evidence for a role of sulphation as an additional regulatory feature of the rate of mucin oligosaccharide has been provided through study of the action of faecal and bacterial extracts on sulphated mucins and sulphated oligosaccharides. T h e presence of mucin oligosaccharide-specific sulphatases is now well established [6,38,40-421. Because of the absence of detailed knowledge on the sulphate substitution in colonic and other mucins the quantitative assay of sulphatase activity with defined substrates has been limited to a few available monosulphated mono-and disaccharides [38, 40, 42] and 35S-radiolabelled mucins [40, 41] . At present there is evidence for individual bacterial enzymes with specificity for galactose-6-0-sulphate and GlcNAc-6-0-sulphate in mucin oligosaccharides.
Testing for sulphatase activity in colonic disease has shown that increased levels of faecal enzyme activity are associated with ulcerative colitis [ 6 ] . T h e absence of satisfactory substrates has hampered such investigations, and the preparation of suitable monosulphated oligosaccharide compounds is required to re-evaluate the situation in disease.
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Concluding remarks
T h e analysis of glycosylation in mucins is enormously complicated through the diversity of structures present in individual molecules, the size of the molecules and the biosynthetic machinery necessary to generate these molecules. In spite of this complexity, certain characteristics have been identified. Sulphation and sialic acid 0-acetylation appear to be important peripheral features of colorectal mucin oligosaccharides. In addition, the alteration of the structure of oligosaccharide chains in disease mucins as a result of changing glycosyltransferase patterns indicates alternative pathways operating in these diseases. Normal function of the mucus defensive barrier is dependent on the correct expression of these moieties, and compromise of the supramucosal defensive layer is implicated in disease processes in which aberrant expression is found. T h e identification of these pathways and the disease-related structures provide the basis for investigation of factors that predispose to these diseases. T h e mucosal surfaces represent an impressive barrier between the 'inside' of the body and the 'outside' world. This 'front line' is under constant threat from micro-organisms, degradative enzymes and other noxious agents and is, therefore, as a first line of defence, covered by a gellike secretion -mucus. T h e polymer matrix of this biofilm is provided by high-M, glycoproteins referred to as mucus glycoproteins or mucins.
The mucin superfamily
Mucins constitute a family of glycoproteins traditionally regarded as secretory products from epithelial surfaces. T h e apoprotein is substituted with a large number of oligosaccharides attached via an 0-glycosidic linkage between serine and/or threonine and GalNAc. In a typical mucin, the 0-linked glycans -often referred to as mucintype oligosaccharides -are enriched within serine/threonine-rich domains. These often contain proline, which is believed to give the protein core an extended conformation, in particular after substitution with the link GalNAc [ l ] , and it is therefore likely that one major function of the serinelthreonine-rich regions is to provide a matrix for the presentation of carbohydrate structures. Similar sequences have been identified in, for example, some membrane-bound glycoproteins, and a 'mucin-like stretch' has become an expression used to denote such domains with multiple sites for substitution with $To whom correspondence should be addressed. whereas MUC7 is a low-M, secreted mucin from saliva previously known as MG2 [4] . T h e other genetically defined mucins are probably large and belong to the biofilm-forming family. Of these, the complete sequence is known only for the human MUC2 mucin [ S ] .
T h e published apoprotein sequences have disclosed many interesting structural features of mucins. T h e heavily glycosylated serinehhreo-
